Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Kidney cortex segmentation in 2D CT with U-Nets ensemble aggregation.

Couteaux V, Si-Mohamed S, Renard-Penna R, Nempont O, Lefevre T, Popoff A, Pizaine G, Villain N, Bloch I, Behr J, Bellin MF, Roy C, Rouvière O, Montagne S, Lassau N, Boussel L.

Diagn Interv Imaging. 2019 Apr;100(4):211-217. doi: 10.1016/j.diii.2019.03.001. Epub 2019 Mar 27.

PMID:
30926445
2.

Diagnosis of focal liver lesions from ultrasound using deep learning.

Schmauch B, Herent P, Jehanno P, Dehaene O, Saillard C, Aubé C, Luciani A, Lassau N, Jégou S.

Diagn Interv Imaging. 2019 Apr;100(4):227-233. doi: 10.1016/j.diii.2019.02.009. Epub 2019 Mar 27.

PMID:
30926443
3.

Five simultaneous artificial intelligence data challenges on ultrasound, CT, and MRI.

Lassau N, Estienne T, de Vomecourt P, Azoulay M, Cagnol J, Garcia G, Majer M, Jehanno E, Renard-Penna R, Balleyguier C, Bidault F, Caramella C, Jacques T, Dubrulle F, Behr J, Poussange N, Bocquet J, Montagne S, Cornelis F, Faruch M, Bresson B, Brunelle S, Jalaguier-Coudray A, Amoretti N, Blum A, Paisant A, Herreros V, Rouviere O, Si-Mohamed S, Di Marco L, Hauger O, Garetier M, Pigneur F, Bergère A, Cyteval C, Fournier L, Malhaire C, Drape JL, Poncelet E, Bordonne C, Cauliez H, Budzik JF, Boisserie M, Willaume T, Molière S, Peyron Faure N, Caius Giurca S, Juhan V, Caramella T, Perrey A, Desmots F, Faivre-Pierre M, Abitbol M, Lotte R, Istrati D, Guenoun D, Luciani A, Zins M, Meder JF, Cotten A.

Diagn Interv Imaging. 2019 Apr;100(4):199-209. doi: 10.1016/j.diii.2019.02.001. Epub 2019 Mar 15.

PMID:
30885592
4.

Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur.

Bourgier C, Auperin A, Rivera S, Boisselier P, Petit B, Lang P, Lassau N, Taourel P, Tetreau R, Azria D, Bourhis J, Deutsch E, Vozenin MC.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):365-373. doi: 10.1016/j.ijrobp.2019.02.024. Epub 2019 Feb 15.

PMID:
30776452
5.

Study of the reliability of quantification methods of dynamic contrast-enhanced ultrasonography: numerical modeling of blood flow in tumor microvascularization.

Boyer L, Leguerney I, Randall Thomas S, Grand-Perret V, Lassau N, Pitre-Champagnat S.

Phys Med Biol. 2018 Aug 23;63(17):17NT01. doi: 10.1088/1361-6560/aad6ae.

PMID:
30136651
6.

New Ultrasound Techniques Challenge the Diagnosis of Sinusoidal Obstruction Syndrome.

Dietrich CF, Trenker C, Fontanilla T, Görg C, Hausmann A, Klein S, Lassau N, Miquel R, Schreiber-Dietrich D, Dong Y.

Ultrasound Med Biol. 2018 Nov;44(11):2171-2182. doi: 10.1016/j.ultrasmedbio.2018.06.002. Epub 2018 Jul 31. Review.

PMID:
30076031
7.

A Novel Microflow Phantom Dedicated to Ultrasound Microvascular Measurements.

Grand-Perret V, Jacquet JR, Leguerney I, Benatsou B, Grégoire JM, Willoquet G, Bouakaz A, Lassau N, Pitre-Champagnat S.

Ultrason Imaging. 2018 Sep;40(5):325-338. doi: 10.1177/0161734618783975. Epub 2018 Jun 20.

PMID:
29923458
8.

The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Short Version).

Sidhu PS, Cantisani V, Dietrich CF, Gilja OH, Saftoiu A, Bartels E, Bertolotto M, Calliada F, Clevert DA, Cosgrove D, Deganello A, D'Onofrio M, Drudi FM, Freeman S, Harvey C, Jenssen C, Jung EM, Klauser AS, Lassau N, Meloni MF, Leen E, Nicolau C, Nolsoe C, Piscaglia F, Prada F, Prosch H, Radzina M, Savelli L, Weskott HP, Wijkstra H.

Ultraschall Med. 2018 Apr;39(2):154-180. doi: 10.1055/s-0044-101254. Epub 2018 Mar 6.

9.

The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version).

Sidhu PS, Cantisani V, Dietrich CF, Gilja OH, Saftoiu A, Bartels E, Bertolotto M, Calliada F, Clevert DA, Cosgrove D, Deganello A, D'Onofrio M, Drudi FM, Freeman S, Harvey C, Jenssen C, Jung EM, Klauser AS, Lassau N, Meloni MF, Leen E, Nicolau C, Nolsoe C, Piscaglia F, Prada F, Prosch H, Radzina M, Savelli L, Weskott HP, Wijkstra H.

Ultraschall Med. 2018 Apr;39(2):e2-e44. doi: 10.1055/a-0586-1107. Epub 2018 Mar 6.

10.

Can we trust the calculation of texture indices of CT images? A phantom study.

Caramella C, Allorant A, Orlhac F, Bidault F, Asselain B, Ammari S, Jaranowski P, Moussier A, Balleyguier C, Lassau N, Pitre-Champagnat S.

Med Phys. 2018 Apr;45(4):1529-1536. doi: 10.1002/mp.12809. Epub 2018 Mar 13.

PMID:
29443389
11.

How to perform Contrast-Enhanced Ultrasound (CEUS).

Dietrich CF, Averkiou M, Nielsen MB, Barr RG, Burns PN, Calliada F, Cantisani V, Choi B, Chammas MC, Clevert DA, Claudon M, Correas JM, Cui XW, Cosgrove D, D'Onofrio M, Dong Y, Eisenbrey J, Fontanilla T, Gilja OH, Ignee A, Jenssen C, Kono Y, Kudo M, Lassau N, Lyshchik A, Franca Meloni M, Moriyasu F, Nolsøe C, Piscaglia F, Radzina M, Saftoiu A, Sidhu PS, Sporea I, Schreiber-Dietrich D, Sirlin CB, Stanczak M, Weskott HP, Wilson SR, Willmann JK, Kim TK, Jang HJ, Vezeridis A, Westerway S.

Ultrasound Int Open. 2018 Jan;4(1):E2-E15. doi: 10.1055/s-0043-123931. Epub 2018 Feb 7. Review.

12.

Molecular Imaging to Predict Response to Targeted Therapies in Renal Cell Carcinoma.

Leguerney I, de Rochefort L, Poirier-Quinot M, Ingels A, Violas X, Robin S, Opolon P, Dubuisson RM, Pitre-Champagnat S, Robert P, Lassau N.

Contrast Media Mol Imaging. 2017 Apr 9;2017:7498538. doi: 10.1155/2017/7498538. eCollection 2017.

13.

Toward a Standardization of Ultrasound Scanners for Dynamic Contrast-Enhanced Ultrasonography: Methodology and Phantoms.

Pitre-Champagnat S, Coiffier B, Jourdain L, Benatsou B, Leguerney I, Lassau N.

Ultrasound Med Biol. 2017 Nov;43(11):2670-2677. doi: 10.1016/j.ultrasmedbio.2017.06.032. Epub 2017 Aug 2.

PMID:
28779957
14.

Real world prospective experience of axitinib in metastatic renal cell carcinoma in a large comprehensive cancer centre.

Matias M, Le Teuff G, Albiges L, Guida A, Brard C, Bacciarelo G, Loriot Y, Massard C, Lassau N, Fizazi K, Escudier B.

Eur J Cancer. 2017 Jul;79:185-192. doi: 10.1016/j.ejca.2017.04.015. Epub 2017 May 13.

PMID:
28511146
15.

A French national breast and thyroid cancer screening programme for survivors of childhood, adolescent and young adult (CAYA) cancers - DeNaCaPST programme.

Demoor-Goldschmidt C, Drui D, Doutriaux I, Michel G, Auquier P, Dumas A, Berger C, Bernier V, Bohrer S, Bondiau PY, Filhon B, Fresneau B, Freycon C, Stefan D, Helfre S, Jackson A, Kerr C, Laprie A, Leseur J, Mahé MA, Oudot C, Pluchard C, Proust S, Sudour-Bonnange H, Vigneron C, Lassau N, Schlumberger M, Conter CF, de Vathaire F.

BMC Cancer. 2017 May 12;17(1):326. doi: 10.1186/s12885-017-3318-1.

16.

French updated recommendations in Stage I to III melanoma treatment and management.

Guillot B, Dalac S, Denis MG, Dupuy A, Emile JF, De La Fouchardiere A, Hindie E, Jouary T, Lassau N, Mirabel X, Piperno Neumann S, De Raucourt S, Vanwijck R.

J Eur Acad Dermatol Venereol. 2017 Apr;31(4):594-602. doi: 10.1111/jdv.14064. Epub 2017 Jan 24.

PMID:
28120528
17.

Study of Intrapatient Variability and Reproducibility of Quantitative Tumor Perfusion Parameters Evaluated With Dynamic Contrast-Enhanced Ultrasonography.

Lassau N, Coiffier B, Faivre L, Benatsou B, Bidault S, Girard E, Asselain B, Pitre-Champagnat S, Koscielny S.

Invest Radiol. 2017 Mar;52(3):148-154. doi: 10.1097/RLI.0000000000000324.

PMID:
28106614
18.

First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas.

Bonvalot S, Le Pechoux C, De Baere T, Kantor G, Buy X, Stoeckle E, Terrier P, Sargos P, Coindre JM, Lassau N, Ait Sarkouh R, Dimitriu M, Borghi E, Levy L, Deutsch E, Soria JC.

Clin Cancer Res. 2017 Feb 15;23(4):908-917. doi: 10.1158/1078-0432.CCR-16-1297. Epub 2016 Oct 6.

19.

Imaging biomarker roadmap for cancer studies.

O'Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, Buckley DL, Chenevert TL, Clarke LP, Collette S, Cook GJ, deSouza NM, Dickson JC, Dive C, Evelhoch JL, Faivre-Finn C, Gallagher FA, Gilbert FJ, Gillies RJ, Goh V, Griffiths JR, Groves AM, Halligan S, Harris AL, Hawkes DJ, Hoekstra OS, Huang EP, Hutton BF, Jackson EF, Jayson GC, Jones A, Koh DM, Lacombe D, Lambin P, Lassau N, Leach MO, Lee TY, Leen EL, Lewis JS, Liu Y, Lythgoe MF, Manoharan P, Maxwell RJ, Miles KA, Morgan B, Morris S, Ng T, Padhani AR, Parker GJ, Partridge M, Pathak AP, Peet AC, Punwani S, Reynolds AR, Robinson SP, Shankar LK, Sharma RA, Soloviev D, Stroobants S, Sullivan DC, Taylor SA, Tofts PS, Tozer GM, van Herk M, Walker-Samuel S, Wason J, Williams KJ, Workman P, Yankeelov TE, Brindle KM, McShane LM, Jackson A, Waterton JC.

Nat Rev Clin Oncol. 2017 Mar;14(3):169-186. doi: 10.1038/nrclinonc.2016.162. Epub 2016 Oct 11. Review.

20.

[Update to the recommendations for management of melanoma stages I to III].

Guillot B, Dalac S, Denis MG, Dupuy A, Emile JF, De La Fouchardière A, Hindie E, Jouary T, Lassau N, Mirabel X, Piperno Neumann S, De Raucourt S, Vanwijck R.

Ann Dermatol Venereol. 2016 Oct;143(10):629-652. doi: 10.1016/j.annder.2016.07.001. Epub 2016 Aug 12. Review. French.

PMID:
27527567
21.

Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab.

Lassau N, Coiffier B, Kind M, Vilgrain V, Lacroix J, Cuinet M, Taieb S, Aziza R, Sarran A, Labbe-Devilliers C, Gallix B, Lucidarme O, Ptak Y, Rocher L, Caquot LM, Chagnon S, Marion D, Luciani A, Feutray S, Uzan-Augui J, Benatsou B, Bonastre J, Koscielny S.

Ann Oncol. 2016 Oct;27(10):1922-8. doi: 10.1093/annonc/mdw280. Epub 2016 Aug 8.

22.

[Guidelines for stage I to III melanoma].

Guillot B, Dalac S, Denis M, Dupuy A, Emile JF, De La Fouchardiere A, Hindie E, Jouary T, Lassau N, Mirabel X, Piperno Neumann S, De Raucourt S, Vanwijck R.

Bull Cancer. 2016 Sep;103(9):743-52. doi: 10.1016/j.bulcan.2016.06.002. Epub 2016 Jul 22. French. No abstract available.

PMID:
27456259
23.

Molecular ultrasound imaging using contrast agents targeting endoglin, vascular endothelial growth factor receptor 2 and integrin.

Leguerney I, Scoazec JY, Gadot N, Robin N, Pénault-Llorca F, Victorin S, Lassau N.

Ultrasound Med Biol. 2015 Jan;41(1):197-207. doi: 10.1016/j.ultrasmedbio.2014.06.014. Epub 2014 Oct 11.

PMID:
25308938
24.

Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization.

Pitre-Champagnat S, Leguerney I, Bosq J, Peronneau P, Kiessling F, Calmels L, Coulot J, Lassau N.

Invest Radiol. 2015 Apr;50(4):212-7. doi: 10.1097/RLI.0000000000000101.

PMID:
25275834
25.

Numerical modelling of the flow of the ultrasound contrast agents in tumour microvasculature.

Boyer L, Le Notre P, Thomas SR, Leguerney I, Lassau N, Pitre-Champagnat S.

Comput Methods Biomech Biomed Engin. 2014;17 Suppl 1:18-9. doi: 10.1080/10255842.2014.931073. No abstract available.

PMID:
25074143
26.

Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study.

Lassau N, Bonastre J, Kind M, Vilgrain V, Lacroix J, Cuinet M, Taieb S, Aziza R, Sarran A, Labbe-Devilliers C, Gallix B, Lucidarme O, Ptak Y, Rocher L, Caquot LM, Chagnon S, Marion D, Luciani A, Feutray S, Uzan-Augui J, Coiffier B, Benastou B, Koscielny S.

Invest Radiol. 2014 Dec;49(12):794-800. doi: 10.1097/RLI.0000000000000085.

27.

Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art.

de Mestier L, Dromain C, d'Assignies G, Scoazec JY, Lassau N, Lebtahi R, Brixi H, Mitry E, Guimbaud R, Courbon F, d'Herbomez M, Cadiot G.

Endocr Relat Cancer. 2014 Apr 28;21(3):R105-20. doi: 10.1530/ERC-13-0365. Print 2014 Jun. Review.

PMID:
24351682
28.

Assessing the response to targeted therapies in renal cell carcinoma: technical insights and practical considerations.

Bex A, Fournier L, Lassau N, Mulders P, Nathan P, Oyen WJ, Powles T.

Eur Urol. 2014 Apr;65(4):766-77. doi: 10.1016/j.eururo.2013.11.031. Epub 2013 Nov 28. Review.

PMID:
24341958
29.

Sorafenib plus dacarbazine in solid tumors: a phase I study with dynamic contrast-enhanced ultrasonography and genomic analysis of sequential tumor biopsy samples.

Lazar V, Lassau N, Meurice G, Loriot Y, Peña C, Massard C, Robert C, Robert T, Le Berre MA, de Baere T, Dessen P, Soria JC, Armand JP.

Invest New Drugs. 2014 Apr;32(2):312-22. doi: 10.1007/s10637-013-9993-0. Epub 2013 Aug 27.

PMID:
23979492
30.

Phase I safety, pharmacokinetic and pharmacodynamic evaluation of the vascular disrupting agent ombrabulin (AVE8062) in patients with advanced solid tumors.

Sessa C, Lorusso P, Tolcher A, Farace F, Lassau N, Delmonte A, Braghetti A, Bahleda R, Cohen P, Hospitel M, Veyrat-Follet C, Soria JC.

Clin Cancer Res. 2013 Sep 1;19(17):4832-42. doi: 10.1158/1078-0432.CCR-13-0427. Epub 2013 Jul 5.

31.

Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results.

Frampas E, Lassau N, Zappa M, Vullierme MP, Koscielny S, Vilgrain V.

Eur J Radiol. 2013 May;82(5):e205-11. doi: 10.1016/j.ejrad.2012.12.004. Epub 2012 Dec 28.

PMID:
23273822
32.

Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.

Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP, Piscaglia F, Wilson SR, Barr RG, Chammas MC, Chaubal NG, Chen MH, Clevert DA, Correas JM, Ding H, Forsberg F, Fowlkes JB, Gibson RN, Goldberg BB, Lassau N, Leen EL, Mattrey RF, Moriyasu F, Solbiati L, Weskott HP, Xu HX; World Federation for Ultrasound in Medicine; European Federation of Societies for Ultrasound.

Ultrasound Med Biol. 2013 Feb;39(2):187-210. doi: 10.1016/j.ultrasmedbio.2012.09.002. Epub 2012 Nov 5.

PMID:
23137926
33.

Early evaluation of targeted drugs using dynamic contrast-enhanced ultrasonography for personalized medicine.

Lassau N, Cosgrove D, Armand JP.

Future Oncol. 2012 Oct;8(10):1215-8. doi: 10.2217/fon.12.114. No abstract available.

PMID:
23130922
34.

Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.

Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP, Piscaglia F, Wilson SR, Barr RG, Chammas MC, Chaubal NG, Chen MH, Clevert DA, Correas JM, Ding H, Forsberg F, Fowlkes JB, Gibson RN, Goldberg BB, Lassau N, Leen EL, Mattrey RF, Moriyasu F, Solbiati L, Weskott HP, Xu HX.

Ultraschall Med. 2013 Feb;34(1):11-29. doi: 10.1055/s-0032-1325499. Epub 2012 Nov 5.

35.

Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques Study.

Lassau N, Chapotot L, Benatsou B, Vilgrain V, Kind M, Lacroix J, Cuinet M, Taieb S, Aziza R, Sarran A, Labbe C, Gallix B, Lucidarme O, Ptak Y, Rocher L, Caquot LM, Chagnon S, Marion D, Luciani A, Uzan-Augui J, Koscielny S.

Invest Radiol. 2012 Dec;47(12):711-6. doi: 10.1097/RLI.0b013e31826dc255.

PMID:
23095862
36.

Impact of the arterial input function on microvascularization parameter measurements using dynamic contrast-enhanced ultrasonography.

Gauthier M, Pitre-Champagnat S, Tabarout F, Leguerney I, Polrot M, Lassau N.

World J Radiol. 2012 Jul 28;4(7):291-301. doi: 10.4329/wjr.v4.i7.291.

37.

An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion.

Dietrich CF, Averkiou MA, Correas JM, Lassau N, Leen E, Piscaglia F.

Ultraschall Med. 2012 Aug;33(4):344-51. Epub 2012 Jul 27.

PMID:
22843433
38.

Virtual patients and sensitivity analysis of the Guyton model of blood pressure regulation: towards individualized models of whole-body physiology.

Moss R, Grosse T, Marchant I, Lassau N, Gueyffier F, Thomas SR.

PLoS Comput Biol. 2012;8(6):e1002571. doi: 10.1371/journal.pcbi.1002571. Epub 2012 Jun 28.

39.

Assessment of quantitative perfusion parameters by dynamic contrast-enhanced sonography using a deconvolution method: an in vitro and in vivo study.

Gauthier M, Tabarout F, Leguerney I, Polrot M, Pitre S, Peronneau P, Lassau N.

J Ultrasound Med. 2012 Apr;31(4):595-608.

PMID:
22441917
40.

Evaluation of treatment response in patients with metastatic renal cell carcinoma: role of state-of-the-art cross-sectional imaging.

Katabathina VS, Lassau N, Pedrosa I, Ng CS, Prasad SR.

Curr Urol Rep. 2012 Feb;13(1):70-81. doi: 10.1007/s11934-011-0233-x. Review.

PMID:
22143974
41.

Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety.

Gomez-Roca CA, Lacroix L, Massard C, De Baere T, Deschamps F, Pramod R, Bahleda R, Deutsch E, Bourgier C, Angevin E, Lazar V, Ribrag V, Koscielny S, Chami L, Lassau N, Dromain C, Robert C, Routier E, Armand JP, Soria JC.

Ann Oncol. 2012 May;23(5):1301-6. doi: 10.1093/annonc/mdr383. Epub 2011 Sep 14.

PMID:
21917737
42.

The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications.

Piscaglia F, Nolsøe C, Dietrich CF, Cosgrove DO, Gilja OH, Bachmann Nielsen M, Albrecht T, Barozzi L, Bertolotto M, Catalano O, Claudon M, Clevert DA, Correas JM, D'Onofrio M, Drudi FM, Eyding J, Giovannini M, Hocke M, Ignee A, Jung EM, Klauser AS, Lassau N, Leen E, Mathis G, Saftoiu A, Seidel G, Sidhu PS, ter Haar G, Timmerman D, Weskott HP.

Ultraschall Med. 2012 Feb;33(1):33-59. doi: 10.1055/s-0031-1281676. Epub 2011 Aug 26. No abstract available.

43.

In vitro evaluation of the impact of ultrasound scanner settings and contrast bolus volume on time-intensity curves.

Gauthier TP, Chebil M, Peronneau P, Lassau N.

Ultrasonics. 2012 Jan;52(1):12-9. doi: 10.1016/j.ultras.2011.06.003. Epub 2011 Jun 13.

PMID:
21722933
44.

Imaging of melanoma: usefulness of ultrasonography before and after contrast injection for diagnosis and early evaluation of treatment.

Chami L, Lassau N, Chebil M, Robert C.

Clin Cosmet Investig Dermatol. 2011;4:1-6. doi: 10.2147/CCID.S13499. Epub 2011 Feb 8.

45.

Estimation of intra-operator variability in perfusion parameter measurements using DCE-US.

Gauthier M, Leguerney I, Thalmensi J, Chebil M, Parisot S, Peronneau P, Roche A, Lassau N.

World J Radiol. 2011 Mar 28;3(3):70-81. doi: 10.4329/wjr.v3.i3.70.

46.

Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments.

Lassau N, Chami L, Chebil M, Benatsou B, Bidault S, Girard E, Abboud G, Roche A.

Discov Med. 2011 Jan;11(56):18-24.

47.

Quantitative functional imaging by dynamic contrast enhanced ultrasonography (DCE-US) in GIST patients treated with masatinib.

Lassau N, Chami L, Koscielny S, Chebil M, Massard C, Benatsou B, Bidault S, Cioffi A, Blay JY, Le Cesne A.

Invest New Drugs. 2012 Apr;30(2):765-71. doi: 10.1007/s10637-010-9592-2. Epub 2010 Dec 7.

PMID:
21136137
48.

Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results.

Lassau N, Koscielny S, Chami L, Chebil M, Benatsou B, Roche A, Ducreux M, Malka D, Boige V.

Radiology. 2011 Jan;258(1):291-300. doi: 10.1148/radiol.10091870. Epub 2010 Oct 27.

PMID:
20980447
49.

Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments.

Leguerney I, Lassau N, Koscielny S, Rodrigues M, Massard C, Rouffiac V, Benatsou B, Thalmensi J, Bawa O, Opolon P, Peronneau P, Roche A.

Invest New Drugs. 2012 Feb;30(1):144-56. doi: 10.1007/s10637-010-9543-y. Epub 2010 Oct 6.

PMID:
20924644
50.

Imaging of perfusion using ultrasound.

Cosgrove D, Lassau N.

Eur J Nucl Med Mol Imaging. 2010 Aug;37 Suppl 1:S65-85. doi: 10.1007/s00259-010-1537-7. Review.

PMID:
20640418

Supplemental Content

Loading ...
Support Center